Aziz Mottiwala is Chief Commercial Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 47,557 shares of TARS, which is worth approximately $2.14 Million. The most recent transaction as insider was on Sep 10, 2021, when has been sold 6,943 shares (Common Stock) at a price of $5.72 per share, resulting in proceeds of $39,714. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.6K
37.11% 3M change
12.05% 12M change
Total Value Held $2.14 Million

Aziz Mottiwala Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 10 2021
BUY
Exercise of conversion of derivative security
$39,714 $5.72 p/Share
6,943 Added 10.25%
60,796 Common Stock
AM

Aziz Mottiwala

Chief Commercial Officer
Irvine, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS